COVID-19 — Worldwide/Unknown
Proud PC, Tsitoura D, Watson RJ, et al. Prophylactic intranasal administration of a TLR2 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model. bioRxiv 2020.09.25.309914; [preprint not certified by peer review]; ]
—-
[B]
Date: Wed 19 Aug 2020
Source: Cell [abridged, edited]
ref: Hassan AO, Kafai NM, Dmitriev IP, et al. A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2. Cell. 2020;
…
